In line with the Ascel Bio forecast, hepatitis A cases have increased since December 2015 and peaked in early May 2016. Ascel Bio projects a steep decline in hepatitis A cases over the summer months of 2016.
Both Ascel Bio forecasts and confirmed cases of hepatitis A show that hepatitis A infections in Taiwan have been steadily increasing since December 2015 and reached a peak in the beginning of May 2016. Confirmed cases of hepatitis A in Taiwan show similar overall patterns to Ascel Bio forecasts, although confirmed cases show more extreme peaks and drops within months when compared to Ascel Bio projections.
Ascel Bio projects a steep decline in cases of hepatitis A in over the next three months.
The Taiwan Centers for Disease Control (CDC) have reported the highest figure for new hepatitis A cases in the first six months of a year with a recorded 275 new cases of hepatitis A so far in 2016. This increase in hepatitis A cases has been localized to the northern half of Taiwan. Men who have sex with men (MSM) have also been identified as having a higher risk of hepatitis A infection due to specific sexual activities that bring individuals in contact with fingers or objects with the virus or in direct contact with feces.
Hepatitis A is spread through the fecal-oral route or through ingestion of food and water contaminated with feces. There is no specific treatment for hepatitis A; however, there are several key ways to prevent infection. Improved sanitation and hand washing, higher standards for food safety, and immunization can all reduce hepatitis A cases. There is currently an effective vaccine for prevention of hepatitis A infection and many countries routinely recommend vaccination for children and unvaccinated adults at risk for hepatitis A infection.